What is the recommended levofloxacin dose for an adult with multidrug-resistant tuberculosis (MDR‑TB)?

Recommended Levofloxacin Dose for MDR-TB in Adults

For adults with multidrug-resistant tuberculosis, the recommended levofloxacin dose is 750-1,000 mg once daily as part of a multidrug regimen. 1

Dosing Algorithm

Standard Dosing (Normal Renal Function)

• 750-1,000 mg once daily is the established guideline recommendation 1, 2
• Levofloxacin is classified as a Group A priority drug in WHO MDR-TB treatment guidelines 3
• The drug should be taken once daily as part of either shorter (6-month) or longer (18-month) MDR-TB regimens 3

Renal Dose Adjustment

If creatinine clearance <50 mL/min:

• Reduce to 750-1,000 mg three times weekly 1
• The drug is 80% renally cleared, making dose adjustment critical 1
• Not removed by hemodialysis - no supplemental doses needed post-dialysis 1

Hepatic Disease

• No dose adjustment required - drug levels unaffected by liver disease 1
• Use with standard monitoring as with all drugs 1

Evidence Strength and Nuances

The 750-1,000 mg daily dose range represents established guideline consensus from multiple authoritative sources 1, 2. However, recent research suggests important considerations:

Higher dose evidence: A 2025 randomized controlled trial (Opti-Q) evaluated doses up to 1,500 mg daily 4. While higher doses (>1,000 mg) achieved greater drug exposures, they:

• Did not result in faster sputum culture conversion
• Increased adverse events (37% vs 16% grade 3-5 AEs in highest vs lowest dose groups)
• The study concluded 1,000 mg daily achieves target exposure in nearly all adults and was well tolerated 4

Pharmacokinetic/pharmacodynamic targets: The optimal AUC₀₋₂₄/MIC ratio for maximal bacterial kill is 146, while suppression of resistance requires 360 5. Monte Carlo simulations suggest:

• 750-1,000 mg achieves >90% target attainment for MIC <0.5 mg/L 6
• 1,500 mg may be needed for strains with MIC of 1 mg/L 6, 7
• However, therapeutic drug monitoring is recommended for strains with MIC ≥0.5 mg/L 7

Critical Administration Details

Drug interactions to avoid:

• Do not administer within 2 hours of antacids, sucralfate, iron, zinc, or other divalent cations 1
• These agents markedly decrease fluoroquinolone absorption 1

Safety monitoring:

• Levofloxacin is preferred over moxifloxacin due to fewer adverse events and less QTc prolongation 3
• Common adverse effects include GI disturbance (0.5-1.8%), neurologic effects (0.5%), and cutaneous reactions (0.2-0.4%) 1

Pregnancy:

• Avoid in pregnancy due to teratogenic effects 1

Common Pitfalls

1. Underdosing: Using 500 mg daily (appropriate for some other infections) is inadequate for MDR-TB - always use 750-1,000 mg 1, 2

2. Ignoring renal function: Failure to adjust for creatinine clearance <50 mL/min leads to drug accumulation 1

3. Coadministration timing: Giving levofloxacin with antacids or multivitamins drastically reduces absorption 1

4. Monotherapy consideration: Levofloxacin must always be part of a multidrug regimen (minimum 4 drugs) to prevent resistance development 3